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Heteroduplex analysis of T-cell receptor g
gene rearrangement as an adjuvant
diagnostic tool in skin biopsies for
erythroderma
Background: Erythroderma, defined as red skin covering most of the Sarah Cherny1, Serena Mraz2,
body surface often accompanied or followed by exfoliation, is the clin- Lyndon Su3, Jeff Harvell1,2 and
ical manifestation of at least six different underlying etiologies with Sabine Kohler1,2
allergic or irritant contact dermatitis, atopic/asteotic dermatitis, pity- Departments of 1Pathology and 2Dermatology,
riasis rubra pilaris (PRP), psoriasis, and seborrheic dermatitis account- Stanford University Medical Center, Stanford
California, USA, Departments of 3Pathology anding for the majority of cases. Approximately 10% of cases are due
Dermatology, University of Michigan, Annto adverse drug reactions with roughly another 10% due to cutaneous
Arbor, Michigan, USAT-cell lymphoma (CTCL), predominantly mycosis fungoides, or leuke-
mia. It is clear from multiple studies that the clinical diagnosis of the
underlying entity is often difficult, as these diseases can present in a
very similar fashion. A skin biopsy is usually employed in this setting
as a diagnostic tool. However, the histopathologic diagnosis of the
underlying cause is complicated by the subtlety of the distinguishing
histologic features. In this situation, an ancillary technique demonstrat-
ing the presence of a monoclonal T-cell proliferation could help to
rule in or out CTCL in cases that clinically and histopathologically do
not allow a definitive diagnosis.
Methods: We retrospectively studied 25 biopsies from sixteen pa-
tients who presented to the Stanford Dermatology Clinic with er-
ythroderma. We examined the specimens morphologically and ana-
lyzed the gamma chain of the T-cell receptor (TCR- g) by polymerase
chain reaction (PCR) followed by heteroduplex analysis for clonality.
We then correlated the results of our PCR and heteroduplex analyses
with the patients’ clinical outcomes.
Results: Four biopsies, from three patients, contained clonal TCR-g
rearrangements; the four biopsies, all of which were equivocal histolog-
ically, correlated to diagnoses of mycosis fungoides (MF) or Sézary
syndrome (SS). Twenty-one biopsies contained polyclonal T-cell
populations. Eighteen of these biopsies represent patients with in-
flammatory dermatoses. Three of these biopsies, all of which were
taken from a single patient, correlate to a diagnosis of MF.
Conclusion: TCR-g PCR heteroduplex analysis seems to represent
an important adjuvant diagnostic tool that, used in conjunction with
histopathology and clinical history, could help to clarify the underlying
etiology of erythroderma.
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Erythroderma, defined as generalized erythema in-
volving at least 90% of the total body surface area
and often accompanied by scaling, occurs in associ-
ation with a variety of disorders.1 History of a pre-
existing dermatosis such as psoriasis, pityriasis rubra
pilaris (PRP), or atopic dermatitis may aid in identify-
ing an underlying cause in some patients. However,
in most cases, identification of the underlying etiology
is difficult since the histopathologic features that nor-
mally distinguish among the different dermatoses are
more subtle in the context of erythroderma.3–5 Er-
ythroderma may be the first manifestation of mycosis
fungoides or Sézary syndrome (SS), which is a triad
of erythrodermic MF, circulating Sézary cells in the
peripheral blood (.5–10%), and clinically enlarged
lymph nodes. Well-defined histologic criteria exist for
patch and plaque stage MF, but erythrodermic MF
can be more difficult to recognize histologically.6,7
While Southern blotting is the gold standard to de-
termine T-cell receptor (TCR) clonality in skin biop-
sies, this procedure has important disadvantages that
have made polymerase chain reaction (PCR)-based
methods a preferred alternative. Southern blotting re-
quires a large amount of high quality DNA that can
only be extracted from unfixed tissue, involves ex-
posure to radioactive isotopes, and is only able to dis-
cern clonal T-cell populations that comprise at least
5% of the total T-cell population. In contrast, the
PCR-based methods are comparatively fast and
simple, can be performed on small quantities of DNA
derived from either fresh or paraffin-embedded tissue
samples, and can detect clonal populations that make
up less than 1% of the T-cells in the sample.3
While multiple other studies have shown the utility
of PCR analysis of the TCR as a tool in detecting a
clonal population of T-cells in skin biopsies,3,8–11
none to our knowledge has approached the topic in
a retrospective fashion, for the specific disease entity
of erythroderma. This is important not only for deter-
mining the procedure’s ability to detect clonality in
the early stages of erythroderma but also for quantify-




We obtained 25 formalin-fixed, paraffin-embedded
tissue samples from sixteen patients, all of whom pre-
sented with erythroderma to the Stanford Derma-
tology Clinic. Nine men and seven women were in-
cluded in the study, ranging in age from 54 to 86
years, with an average age of 72.2 years. All tissue-
samples were taken at the time of presentation with
erythroderma and were obtained between 1996 and
1999, and only the patients for whom we had suf-
ficient follow-up clinical information, as determined
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by review of the patients’ charts, were included in the
study.
PCR and heteroduplex analysis
Amplification and heteroduplex analysis of the TCR-
g chain was performed as previously described.12
Consensus primers for the TCR-g V-J junction were
used to amplify genomic DNA isolated from paraffin-
embedded tissue. The amplification of the TCR-g V-
J junction was performed in a Perkin-Elmer 2400
thermal cycler with a single set of consensus primers:
V1 (5ø-TACATCCACTGGTACCTACACCA-3ø)
for the V g 1 family (V g 1–8) and J1/2 (5ø-CCCGT-
CGACTACCTTGGAAATGTTGTATTCTTC-3ø)
for the J g 1 and J g 2 segments. Positive and negative
controls were included in all PCR reactions.
Conditions were as follows: 100–500 ng of genomic
DNA was added to a reaction mixture containing
2.5U AmpliTaq Gold polymerase (Perkin-Elmer, Fos-
ter City, CA, USA), 10 pM of each primer, 125 mM
of each dNTP, in Perkin-Elmer PCR buffer II (10
mM Tris-HCl, pH 8.3, 50 mM KCl) with 1.5 mM
MgCl2. After 95 æC denaturation the TCR-g was
amplified as follows: 20 cycles of 95 æC denaturation
(40 s), 65 æC annealing (30 s), decreasing by 1 æC/
cycle, 72 æC extension (30 s), followed by 15 cycles
with the same denaturing and extension temperatures
and an annealing temperature of 45C, followed by a
final 72 æC extension for 5 min.
PCR products were first visualized on a 2% agar-
ose gel to document successful amplification. Twenty
mL of the PCR product with 2 mL of 0.05 M EDTA
added was heated to 95 æC for 10 min and then slowly
cooled to 37 æC over 30 min using the thermal cycler,
then placed on ice. The samples were then electro-
phoresed on a Mutation Detection Enhancement
(MDE) gel (FMC Bioproducts, Rocklands, ME,
USA), for 12 h at 80 V in tris-borate-EDTA buffer.
Heteroduplex patterns were then determined by
staining with ethyidium bromide and photography on
ultraviolet (UV) light.
We excluded any samples pre-dating 1996 from the
study due to deterioration of the DNA. Some such
samples produced a band on gel electrophoresis fol-
lowing b-globin PCR, performed prior to TCR-g
PCR to check the integrity of the DNA. However,
the samples did not produce bands following TCR-g




Clinical follow-up was available for all patients in the
study, and ranged from 8 to 37 months, with an aver-
age of 19 months. Of the nine men and seven women
Heteroduplex analysis for erythroderma
Table 1. PCR Results and clinical follow-up
patient . age and sex follow-up clinical follow-up PCR
1 70, F 37 months drug reaction ª
2 73, F 33 months psoriasis ª
3 71, M 31 months asteotic/atopic dermatitis ª
4a 86, M 29 months contact dermatitis ª
4b 86, M 29 months contact dermatitis ª
5 72, M 28 months asteotic/atopic dermatitis ª
6a 72, M 18 months contact dermatitis ª
6b 72, M 18 months contact dermatitis ª
7a 56, M 17 months MF ª
7b 56, M 17 months MF π
7c 56, M 17 months MF ª
7d 56, M 17 months MF ª
8a 83, F 17 months contact dermatitis ª
8b 83, F 17 months contact dermatitis ª
9 86, F 16 months asteotic/atopic dermatitis ª
10 73, F 15 months drug reaction ª
11 79, F 14 months psoriasis ª
12a 71, M 12 months PRP, diagnosed 12/98 ª
12b 71, M 12 months PRP, diagnosed 12/98 ª
13 77, F 12 months drug reaction ª
14 58, M 10 months MF/SS π
15a 74, M 9 months drug reaction ª
15b 74, M 9 months drug reaction ª
16a 54, M 8 months MF/SS π
16b 54, M 8 months MF/SS π
mean: 72.2 mean: 19 mo
range: 54–86 range:8 –37 mo
9 M, 7 W
included in the study, three were diagnosed with MF,
as determined by file review; the remaining thirteen
patients’ erythroderma was determined to be due to
a variety of conditions: asteotic/atopic dermatitis
(3 patients), generalized contact dermatitis (3 pa-
tients), drug reactions (4 patients), psoriasis (2 pa-
tients), and PRP (1 patient).
Diagnoses for the three patients with MF were
based on the following: Patient .7 had 30% circu-
lating Sézary cells and developed lymphadenopathy
within one year after presenting with erythroderma.
At the time of original presentation, however, the pa-
tient had no lymphadenopathy and no blood work
was done. Patient .14 had a history of stage 1a my-
cosis fungoides prior to presenting with erythroderma
and had 30% circulating Sézary cells and lymph-
adenopathy at the time of presentation with erythrod-
erma. Patient .16 had biopsy-confirmed involvement
of an inguinal lymph node with mycosis fungoides
and had .30% circulating Sézary cells at the time of
presentation with erythroderma.
Diagnoses for patients with drug reactions (patients
.1, 10, 13, 15) were based on the observations that
the patients’ symptoms cleared after removal of the
offending agent. Patients who were determined to
have atopic dermatitis (patients .3, 5, 9) had signifi-
cant atopic histories and improved with aggressive
skin emoliation and mid-strength topical steroid ther-
apy. Patients with a diagnosis of contact dermatitis
(patients .4, 6, 8) cleared with topical and/or oral
corticosteroid therapy and did not recur after avoid-
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ance of the offending agent. Patients .6 and .8 had
positive reactions to allergic patch testing, and patient
.4 had a suspected source of allergy found through
clinical history. The patients with psoriasis (patients
.2 and 11) both had a history of plaque-type psoriasis
prior to presenting with erythroderma. Patient .2 had
mild patch-type disease for 5 years prior to develop-
ing erythroderma and continued to have typical
patches of psoriasis that waxed and waned in severity
after the erythroderma was treated with aggressive
topical therapy. Patient .11 was known to have a long
history of severe psoriasis prior to developing erythro-
derma and, with improved control of her disease, she
continues to have typical plaques of psoriasis. Patient
.12 had classical ‘‘islands of sparing’’ and had pal-
mar-plantar hyperkeratosis and coloration typical of
pityriasis rubra pilaris. Furthermore, his response to
treatment with an oral retinoid was in keeping for
PRP.
Table 1 summarizes the clinical data. The PCR
analysis was performed in a retrospective fashion and
did not play a role in establishing a final clinical diag-
nosis.
Molecular studies
Four of the 25 biopsies contained clonal T-cell pro-
liferations as shown by TCR-g rearrangements; all
four biopsies were from patients with MF. The
twenty-one biopsies with polyclonal T-cell popula-
tions represent patients who, through file review, were
determined to have atopic dermatitis, allergic or irri-
tant contact dermatitis, drug reactions, PRP, psoriasis,
pemphigus foliaceous, or, in one case, MF. Through
serial dilutions of our positive control (DNA extracted
from a lymph node with peripheral T-cell lymphoma)
in our negative control (DNA extracted from tonsil),
we established that a clonal T-cell population com-
prising less than 1% of the total DNA produced a
positive result on heteroduplex analysis. Results of the
TCR- g PCR are included in Table 1.
Discussion
The difficulty of identifying the underlying etiology
of erythroderma through histopathology alone is well
established, and several articles address this issue.1, 2,
4, 5 Walsh et al. examined 56 skin biopsies from 40
erythrodermic patients and found that the mean ac-
curacy of the histopathological diagnoses was 53%,
with a range of 48–66%; accuracy varied by pathol-
ogist as well as by diagnosis, e.g., the greatest degree
of accuracy was observed in cases of spongiotic der-
matitis and the least in those of PRP.4 Kohler et al.
describe the difficulties in identifying erythrodermic
MF and Sézary syndrome patients: although clearly
defined histologic parameters exist for diagnoses of
Cherny et al.
MF in well-developed patch and plaque stages, the
same histologic parameters do not hold true for those
patients who present with erythroderma.6 Botella-Es-
trada et al. also acknowledge the difficulty of assigning
etiology to erythroderma through histopathology
alone, citing that several biopsies were necessary be-
fore establishing a final diagnosis in eight out of a
total of 36 biopsies from erythrodermic patients
evaluated. Although the 36 patients collectively repre-
sented a variety of final diagnoses, of the eight pa-
tients that required multiple biopsies, five of them had
CTCL, suggesting that erythrodermic CTCL has an
especially challenging histopathology.1 Clearly, it
would be beneficial to both patient and physician to
be able to establish a diagnosis more quickly and
more accurately with diminished need for multiple
biopsies from each patient.
Multiple studies have evaluated the utility of PCR
as a diagnostic aide in evaluating potential CTCL
cases. Guitart and Kaul analyzed skin biopsies from
48 patients with ‘‘possible CTCL.’’ Twenty-six of the
48 patients proved to have CTCL; of those 26, 19
(73%) showed a clonal proliferation with PCR.10 Sig-
noretti et al., in a similar study, found a clonal pro-
liferation in 20 out of 21 (95%) of T-cell lymphoma
cases.9
To the best of our knowledge, no studies have fo-
cused on the utility of TCR- g PCR in erythrodermic
patients. With this study, we aimed to evaluate the
effectiveness of establishing clonality in CTCL pre-
senting as erythroderma. Additionally, we evaluated
the potential for false-positives among the polyclonal
inflammatory infiltrates associated with the majority
of erythrodermic patients. In our study, 25 biopsies
from sixteen patients were analyzed by TCR-g PCR
and the results were correlated with the patients’ clin-
ical outcomes as determined through file review. Four
of the 25 biopsies contained clonal TCR-g rearrange-
ments; all four represented biopsies from patients who
proved to have MF. These results correspond to
100% specificity and a 0% false-positive rate in this
limited sample size. The remaining 21 negative TCR-
g PCR results, indicating polyclonal T-cell popula-
tions, represent thirteen different patients; 12 of these
patients had inflammatory dermatoses while one pa-
tient had MF. Over the course of one month, this
particular patient had four biopsies, .7a-d, all of
which were included in our study. The first two, 7a
and 7b, were taken while the patient was on topical
steroids, prescribed for the patient’s ongoing papular
rash of unknown etiology. The second set, 7c and 7d,
were taken after the patient had discontinued his top-
ical therapy for a period of 3 weeks. The histopath-
ology was similarly equivocal in both sets of biopsies.
During our study, one of the four biopsies produced
a clonal band, whereas the remaining three did not.
This not only underscores the importance of multiple
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biopsies, especially in patients who may be clinically
suspicious for MF, but also adds weight to the pres-
ence of a positive clonal result in even one of the
biopsies. It is likely that the three negative biopsies
contained infiltrates that were below the threshold of
detection. This patient’s diagnosis was confirmed one
year after the original presentation by the presence of
circulating Sézary cells and lymph node involvement
of T-cell lymphoma.
In conclusion, a more sensitive and specific diag-
nostic procedure for patients presenting with erythro-
derma would mean more appropriate and earlier in-
stituted therapy, especially in the case of patients with
CTCL, and avoidance of serial biopsies, particularly
when the histology is ambiguous. Our study is based
on a small sample of patients with a relatively short
follow-up period, and similar studies with larger num-
bers of subjects would be necessary to substantiate our
conclusions. In our hands, TCR-g PCR heteroduplex
analysis seems to represent an important adjuvant di-
agnostic tool that, used in concert with histopathology
and clinical history, can help to clarify underlying
etiology of erythroderma.
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